NDC 61919-147-90 - Methocarbamol
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 61919-147
- Requested NDC
- 61919-147-90
- Package NDCs from labels
- 61919-147-90, 61919-147-60, 61919-147-30
- Manufacturer
- Direct RX
- Effective date
- 2015-11-03
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Methocarbamol - Direct RX | Direct RX | 2015-11-03 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 61919-147-30 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-fe53-f424-e053-dadaa90a57ce | Methocarbamol |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 61919-147-30 | Methocarbamol | 30 in 1 BOTTLE | TABLET | 30 | 4 | |
| 61919-147-60 | Methocarbamol | 60 in 1 BOTTLE | TABLET | 60 | 4 | |
| 61919-147-90 | Methocarbamol | 90 in 1 BOTTLE | TABLET | 90 | 4 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 61919-147-30 | EA - Each | 61919-147 | dc506099-ab75-4b23-9e49-8202ba08a63b | 1 | 2015-04-03 |
| 61919-147-60 | EA - Each | 61919-147 | bfb4b69e-7aab-49c5-9265-8eb63c496717 | 1 | 2015-10-02 |
| 61919-147-90 | EA - Each | 61919-147 | e56ac755-bd34-4a99-a6a2-e134db5860c6 | 1 | 2015-10-02 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| METHOCARBAMOL | ACTIVE INGREDIENT | 125OD7737X | METHOCARBAMOL TABLET [DIRECT RX] | 4 | |
| METHOCARBAMOL | ACTIVE MOIETY | 125OD7737X | METHOCARBAMOL TABLET [DIRECT RX] | 4 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | METHOCARBAMOL TABLET [DIRECT RX] | 4 | |
| POVIDONE | INACTIVE INGREDIENT | FZ989GH94E | METHOCARBAMOL TABLET [DIRECT RX] | 4 | |
| SODIUM STARCH GLYCOLATE TYPE A POTATO | INACTIVE INGREDIENT | 5856J3G2A2 | METHOCARBAMOL TABLET [DIRECT RX] | 4 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Methocarbamol Tablets, USP, 500 mg | METHOCARBAMOL | Marlex Pharmaceuticals, Inc. | d2e38ac9-1cf3-14ca-e053-2a95a90a8522 | 2026-11-06 | Warnings, Adverse reactions | 197944 197943 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Doc Rx | 5e55526f-bb34-4b67-85ea-b2765e8066bb | 2026-11-05 | Warnings, Adverse reactions | 197943 125OD7737X |
| Methocarbamol | METHOCARBAMOL TABLETS | NuCare Pharmaceuticals,Inc. | 72f36d28-15d2-30f6-e053-2a91aa0ad1ce | 2026-11-05 | Warnings, Adverse reactions | 197943 125OD7737X |
| Methocarbamol Tablets, USP, 500 mg | METHOCARBAMOL | PD-Rx Pharmaceuticals, Inc. | 6500c6eb-fa1e-46a5-839f-13047e107e97 | 2026-11-04 | Warnings, Adverse reactions | 197943 125OD7737X |
| Methocarbamol Tablets, USP, 500 mg | METHOCARBAMOL | PD-Rx Pharmaceuticals, Inc. | 6ca768bf-5095-4148-82d2-a0c2dec16d87 | 2026-11-03 | Warnings, Adverse reactions | 197943 125OD7737X |
| Methocarbamol | METHOCARBAMOL TABLETS | American Health Packaging | 1b5afc6c-e09c-41bd-8b7e-d12051b33a4b | 2026-10-29 | Warnings, Adverse reactions | 197944 197943 125OD7737X |
| Clear Eyes Triple Relief | POLYVINYL ALCOHOL AND POVIDONE AND TETRAHYDROZOLINE HYDROCHLORIDE | Prestige Brands Holdings, Inc. | 1269a1a6-843d-4d08-bb3c-c1f3d2e7080d | 2026-10-23 | Warnings | FZ989GH94E |
| Methocarbamol | METHOCARBAMOL | A-S Medication Solutions | d8e3f8dc-9751-419b-8601-d85c43415c82 | 2026-10-16 | Warnings, Adverse reactions | 197944 125OD7737X |
| Methocarbamol | METHOCARBAMOL | A-S Medication Solutions | d217bd1d-0b6e-4a4c-a47b-de73b94e8b13 | 2026-10-16 | Warnings, Adverse reactions | 197944 125OD7737X |
| Methocarbamol | METHOCARBAMOL | REGIMED MEDICAL | d4433a71-5cf9-4a32-8902-1c522f1a9acd | 2026-10-13 | Warnings, Adverse reactions | 197943 125OD7737X |
| Methocarbamol | METHOCARBAMOL TABLETS | Granules India Ltd | 42c0a177-7d62-4bcf-9fce-7dd484cda4d5 | 2026-10-07 | Warnings, Adverse reactions | 197944 197943 125OD7737X |
| METHOCARBAMOL | METHOCARBAMOL | Henry Schein, Inc | d48d76af-b55a-4908-95ff-e7de615c0513 | 2026-10-05 | Warnings, Adverse reactions | 125OD7737X |
| Methocarbamol | METHOCARBAMOL | ASCLEMED USA INC. | 077fa923-bee0-4b34-a52d-6f870bcb4828 | 2026-09-29 | Warnings, Adverse reactions | 197943 125OD7737X |
| Methocarbamol | METHOCARBAMOL TABLETS | PD-Rx Pharmaceuticals, Inc. | 7dafab15-db4c-4425-b1a2-e56433ecccf6 | 2026-09-23 | Warnings, Adverse reactions | 197943 125OD7737X |
| Methocarbamol | METHOCARBAMOL TABLETS | PD-Rx Pharmaceuticals, Inc. | d0acdf52-e1a9-4489-91e1-ef434d311613 | 2026-09-23 | Warnings, Adverse reactions | 197944 125OD7737X |
| Methocarbamol | METHOCARBAMOL TABLETS | A-S Medication Solutions | e5fe4627-11cb-4ebd-8eb0-9be807446fdf | 2026-09-23 | Warnings, Adverse reactions | 197944 125OD7737X |
| Methocarbamol | METHOCARBAMOL | St. Mary's Medical Park Pharmacy | 5bc70fe6-67a6-795b-e063-6394a90a1193 | 2026-09-17 | Warnings, Adverse reactions | 197943 125OD7737X |
| Methocarbamol | METHOCARBAMOL | Aphena Pharma Solutions - Tennessee, LLC | 5b9b48e2-4ff4-3ceb-e063-6394a90a0499 | 2026-09-16 | Warnings, Adverse reactions | 197944 125OD7737X |
| REFRESH Classic | POLYVINYL ALCOHOL, POVIDONE | Allergan, Inc. | 31bf1d6c-9719-4060-b6a3-409a2fe7b560 | 2026-09-15 | Warnings | FZ989GH94E |
| Methocarbamol | METHOCARBAMOL TABLETS | REMEDYREPACK INC. | 3e4c88fe-bc3d-463f-973c-e52062e4d4ba | 2026-09-14 | Warnings, Adverse reactions | 197944 125OD7737X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.